These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 2189133

  • 1. Erythropoietin therapy in autologous blood donors.
    Goodnough LT.
    Prog Clin Biol Res; 1990; 338():105-12. PubMed ID: 2189133
    [No Abstract] [Full Text] [Related]

  • 2. Potential role of recombinant human erythropoietin in the peri-surgical setting.
    Goodnough LT.
    Int J Cell Cloning; 1990 Jan; 8 Suppl 1():203-10. PubMed ID: 2182736
    [Abstract] [Full Text] [Related]

  • 3. The effect of patient size and dose of recombinant human erythropoietin therapy on red blood cell volume expansion in autologous blood donors for elective orthopedic operation.
    Goodnough LT, Verbrugge D, Marcus RE, Goldberg V.
    J Am Coll Surg; 1994 Aug; 179(2):171-6. PubMed ID: 8044386
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Erythropoietin therapy in AIDS.
    Henry DH.
    Prog Clin Biol Res; 1990 Aug; 338():113-20. PubMed ID: 2189134
    [No Abstract] [Full Text] [Related]

  • 6. Use of preoperative erythropoietin therapy to facilitate autologous blood donation in orthopedic surgery: A meta-analysis.
    Chang X, Li Q, Tang H.
    Medicine (Baltimore); 2020 Jan; 99(2):e18577. PubMed ID: 31914036
    [Abstract] [Full Text] [Related]

  • 7. [Effects of subcutaneous administration of erythropoietin on autologous blood predonation in open heart surgery: Japanese multicenter double-blinded dose-study].
    Omoto R, Kyo S, Furuse A, Hosoda Y, Eguchi S, Matsuda H, Kito Y, Hirashima K, Ogawa N.
    Rinsho Kyobu Geka; 1994 Dec; 14(6):510-21. PubMed ID: 9423132
    [Abstract] [Full Text] [Related]

  • 8. Minimizing perioperative homologous blood exposure with recombinant human erythropoietin.
    Levine EA, Gould SA.
    Surg Annu; 1993 Dec; 25 Pt 1():83-99. PubMed ID: 8416148
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Definition of a target population for utilization of recombinant erythropoietin with a view to taking of delayed autologous blood].
    Fournel JJ.
    Nouv Rev Fr Hematol (1978); 1995 Dec; 37 Suppl 1():S27-36. PubMed ID: 7478982
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Minimal effective dosage of recombinant human erythropoietin in spinal surgery.
    Lee JH, Lee SH, Oh JH.
    Clin Orthop Relat Res; 2003 Jul; (412):71-6. PubMed ID: 12838055
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Usefulness of recombinant human erythropoietin on predeposit autologous blood transfusion in patients undergoing radical prostatectomy].
    Hashine K, Karashima T, Kasahara K, Sumiyoshi Y.
    Hinyokika Kiyo; 1997 Jun; 43(6):411-4. PubMed ID: 9250490
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Limitations of the erythropoietic response to serial phlebotomy: implications for autologous blood donor programs.
    Goodnough LT, Brittenham GM.
    J Lab Clin Med; 1990 Jan; 115(1):28-35. PubMed ID: 2299254
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.